Clinical Trials Logo

Menopause clinical trials

View clinical trials related to Menopause.

Filter by:

NCT ID: NCT01933295 Completed - Menopause Clinical Trials

Behavioral Treatment of Menopausal Insomnia; Sleep and Daytime Outcomes

Start date: March 1, 2014
Phase: N/A
Study type: Interventional

Insomnia is recognized as the most prevalent and "costly" sleep disorders and is associated with considerable morbidity including significantly reduced quality of life, impaired work performance, and increased risk for major depressive disorder.1-4 Insomnia is a key symptom of the menopausal transition. Cognitive-behavioral therapy for insomnia (CBT-I) yields equivalent short-term efficacy and superior long-term durability to pharmacological treatment of insomnia. The efficacy of cognitive behavioral therapy for insomnia comorbid with menopause will be tested.

NCT ID: NCT01931436 Completed - Menopause Clinical Trials

Pharmacokinetics Study of Qing'E Pill

Start date: August 2013
Phase: Phase 1
Study type: Interventional

This study will investigate the pharmacokinetics of single and multiple doses of Qing'E pills in Chinese menopause volunteers. The main components of Qing'E pill into the blood such as psoralen and Isopsoralen will be detected.

NCT ID: NCT01918072 Completed - Clinical trials for Urinary Incontinence

Controlled Trial of Tele-Support and Education for Womens Health Care in CBOCs

WH CREATE P4
Start date: March 1, 2013
Phase:
Study type: Observational

VA community-based outpatient clinics (CBOCs) typically serve only a small number of women Veterans, and generally do not have the women's health care resources that are available in larger settings. Women Veterans using these sites for primary care must sometimes travel to other sites to receive women's health care. That can create travel burdens, reduce continuity of care, and negatively affect patient outcomes. To address this, VA is implementing a clinical operations innovation that supports women's primary care providers with a technology-based intervention that combines interactive communication with women's health specialists and ongoing education. This research study is evaluating the implementation and effects of this women's healthcare delivery innovation. Findings from this research will inform VA women's health clinical practice and education, and will advance science in delivering technology-supported non-face-to-face care that is applicable to other clinical conditions and patient populations.

NCT ID: NCT01908270 Completed - Breast Cancer Clinical Trials

Effects of Yoga on Menopausal Symptoms in Women With Breast Cancer

Start date: August 2013
Phase: N/A
Study type: Interventional

Women with breast cancer and breast cancer survivors are often bothered by menopausal symptoms to a special degree. Treatment options for those symptoms are currently limited as hormone replacement therapy is often prohibited. Yoga has been shown to reduce menopausal symptoms as well as symptoms associated with breast cancer. Therefore, this study aims to investigate whether a 12-week yoga intervention can reduce menopausal symptoms in women with breast cancer and breast cancer survivors.

NCT ID: NCT01899612 Completed - Menopause Clinical Trials

Vaginal Inflammation Markers in Postmenopausal Women With and Without Symptoms of Vaginal Inflammation

Start date: August 2010
Phase: N/A
Study type: Observational

Many postmenopausal women suffer from vaginal symptoms such as dryness, itching, and painful intercourse. The underlying pathology is unknown. Since symptoms are comparable to those found in infectious vaginitis during the reproductive life stage, the investigators hypothesize that the vaginal milieu in symptomatic postmenopausal women is comparable to inflammation in vaginitis. The investigators therefore study vaginal cytokines in symptomatic and asymptomatic postmenopausal women.

NCT ID: NCT01895881 Withdrawn - Menopause Clinical Trials

Estrogen Therapy as Prevention in the Progression of Aneurysm (EPPA) Trial

EPPA
Start date: April 2013
Phase: Phase 2
Study type: Interventional

This study aims to determine if hormone replacement therapy, given during perimenopause may prevent the progression of saccular cerebral aneurysms.

NCT ID: NCT01862861 Completed - Menopause Clinical Trials

Relieving Vasomotor Symptoms Effectively With Bioidentical Hormone Replacement Therapy: The REVERT Study

REVERT
Start date: November 2012
Phase: N/A
Study type: Observational

Bioidentical Hormone Replacement Therapy (BHRT) to assess a change in the number of various menopausal symptoms such as hot flashes and night sweats in surgically or naturally induced peri or post-menopausal women.

NCT ID: NCT01816360 Completed - Menopause Clinical Trials

Aromatherapy and Yogatherapy for Hot Flashes

Start date: January 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to verify and analyse psychological and physiological effects of olfactory aromatherapy and yogatherapy respiratory exercises, together and separately, on the quality of life, levels of stress, quality of sleep and intensity and frequence of hot flashes in climacteric women.

NCT ID: NCT01805765 Completed - Menopause Clinical Trials

Qing'E Formula Therapy on Menopausal Symptoms

Start date: March 2013
Phase: Phase 2/Phase 3
Study type: Interventional

The objective of this study is to evaluate whether a Chinese medicine formula (Qing'E) is effective in alleviating menopausal symptoms and safety.

NCT ID: NCT01805674 Completed - Menopause Clinical Trials

Isoflavones and Magnolia Extract in the Quality of Life in Menopausal Women

ESTROCALVI
Start date: March 2013
Phase: N/A
Study type: Observational

In menopause, the vasomotor symptomatology, accompanied or less by affective and behavioural symptoms, globally worsens the quality of daily life. The improvement of the quality could be reached with adequate food supplements, named phytoestrogens, in particular Soy Isoflavones (SI), which are natural substances with estrogen-like and estrogen-antagonistic activity, which are active in the control of menopausal vasomotor symptoms. Besides, combined with magnolia extract it could improve the psychological symptomatology also improving the quality of life.